Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

This study has been completed.
Sponsor:
Collaborators:
Commission of higher education (CHE), Ministry of Education, Thailand
National Health Security Office, Thailand
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT01225406
First received: October 18, 2010
Last updated: March 26, 2015
Last verified: March 2015